The oncology field marks notable advances: NucleoBio and PreCheck Health Services collaborate on a novel prostate cancer test using qPCR and machine learning to detect RNA biomarkers in men of African ancestry. MIT scientists develop antibody-bottlebrush conjugates (ABCs) allowing higher drug loading and reduced toxicity compared to antibody-drug conjugates. Penn engineers explore tumor mechanics and extracellular vesicles to better understand cancer progression. These innovations collectively boost precision in cancer diagnostics and therapies.